Sugi Predict

Sugi Predict / Compounds / SCHEMBL2015376

SCHEMBL2015376

SCHEMBL2015376

N#Cc1ccc2c(c1)CCC(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.50
▸ MAPK13 O15264 1/20 0.50
▸ MAPK12 P53778 1/20 0.50
▸ MAPK11 Q15759 1/20 0.50
▸ MAPK14 Q16539 1/20 0.50
▸ KIF11 P52732 2/20 0.49
▸ TBXAS1 P24557 2/20 0.46
▸ PDE3B Q13370 2/20 0.46
▸ PDE3A Q14432 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP11B1 P15538 2/20 0.46
▸ CYP11B2 P19099 2/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ DRD2 P14416 2/20 0.45
▸ DRD3 P35462 2/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ PNMT P11086 1/20 0.45
▸ MAOA P21397 3/20 0.44
▸ MAOB P27338 3/20 0.44
▸ CRBN Q96SW2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30100790 1.00 NPC1 (0.50) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL15964812 0.90 MAPT (0.53) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL3306017 0.87 KIF11 (0.62) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1722699 0.86 CA9 (0.57) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL261156 0.84 PGR (0.56) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL29771067 0.84 PGR (0.56) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL3310037 0.84 CYP11B1 (0.58) NPC1KIF11TBXAS1PDE3BPDE3A
SCHEMBL10464380 0.83 NPC1 (0.50) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL11042468 0.77 NR3C1 (0.54) PDE3BPDE3ACRBNALDH1A1
SCHEMBL31718489 0.77 CRBN (0.50) KIF11PDE3BPDE3AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 — — US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 — — US disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 — — EP disclosed
WO-2021151062-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERISTY (US) 2021-07-29 — — WO disclosed
CN-107207440-B 2-oxo-3, 4-dihydroquinoline compounds as plant growth regulators 先正达参股股份有限公司 2020-11-10 — — CN disclosed
US-10392348-B2 2-oxo-3,4-dihydroquinoline compounds as plant growth regulators SYNGENTA PARTICIPATIONS AG (CH) 2019-08-27 — — US disclosed
US-10392348-B2 2-oxo-3,4-dihydroquinoline compounds as plant growth regulators SYNGENTA PARTICIPATIONS AG (CH) 2019-08-27 — — US disclosed
EP-3256447-B1 2-OXO-3,4-DIHYDROQUINOLINE COMPOUNDS AS PLANT GROWTH REGULATORS SYNGENTA PARTICIPATIONS AG (CH) 2019-06-05 — — EP disclosed
EP-3256447-B1 2-OXO-3,4-DIHYDROQUINOLINE COMPOUNDS AS PLANT GROWTH REGULATORS SYNGENTA PARTICIPATIONS AG (CH) 2019-06-05 — — EP disclosed
US-20180044297-A1 2-OXO-3,4-DIHYDROQUINOLINE COMPOUNDS AS PLANT GROWTH REGULATORS SYNGENTA PARTICIPATIONS AG (CH) 2018-02-15 — — US disclosed
US-8759366-B2 Aminopyrimidines as SYK inhibitors MERCK SHARP & DOHME CORP. (US) 2014-06-24 — — US disclosed
US-8551984-B2 Aminopyrimidines as SYK inhibitors MERCK SHARP & DOHME CORP. (US) 2013-10-08 — — US disclosed
US-20120277192-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME LLC 2012-11-01 — — US disclosed
EP-2513098-A1 AMINOPYRIMIDINES AS SYK INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-10-24 — — EP disclosed
US-20110245205-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME LLC 2011-10-06 — — US disclosed
WO-2011075515-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-06-23 — — WO disclosed
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 — — US disclosed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 — — US disclosed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 — — EP disclosed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392348-B2 2-oxo-3,4-dihydroquinoline compounds as plant growth regulators CDC25B, OSR1, CDC25C NPC1 4459/4885MAPK13 1536/4885MAPK12 555/4885
US-20110245205-A1 AMINOPYRIMIDINES AS SYK INHIBITORS SYK, BTK, LCK NPC1 4448/4885MAPK13 1175/4885MAPK12 1329/4885
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R NPC1 1593/4885MAPK13 3699/4885MAPK12 2133/4885
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 NPC1 2907/4885MAPK13 1513/4885MAPK12 1578/4885
US-20180044297-A1 2-OXO-3,4-DIHYDROQUINOLINE COMPOUNDS AS PLANT GROWTH REGULATORS CDC25B, OSR1, CDC25C NPC1 4459/4885MAPK13 1536/4885MAPK12 555/4885
US-20120277192-A1 AMINOPYRIMIDINES AS SYK INHIBITORS SYK, BTK, LCK NPC1 4448/4885MAPK13 1175/4885MAPK12 1329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback